Insidermedicine in 60 - April 1 2008

Description: From Cleveland - The weight loss drug Acomplia may alter certain risk factors for heart disease, but doesn't appear to reverse it. Researchers randomized over 800 patients who required an angiogram to receive either Acomplia or placebo. Using intravascular ultrasound, no differences were noted in those who received the two treatments. Those who received Acomplia lost more weight and had a greater reduction in triglycerides, but were also more likely to develop psychiatric symptoms. From ...